Top Markets
#1 Black Phoenix Black Phoenix +346.11%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +67.06%
#4 Gold Park Gold Park +58.03%
#5 Acurast Acurast +36.59%
#6 OpenEden OpenEden +32.83%
#7 BasedHype BasedHype +27.23%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.76%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +16.89%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals, Inc.

TFFP
Classement en actions #40710
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals,... Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.
Prix de l'action
$0.065
Dernière synchronisation: 2025-01-10
Capitalisation boursière
$94.10K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange TFF Pharmaceuticals, Inc. (TFFP)

Catégorie

Healthcare
Le prix TFFP avec la capitalisation boursière de B
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
TFFP
$0.065
Capitalisation boursière de TFF Pharmaceuticals, Inc.(TFFP)
Capitalisation boursière: $94.10K
En August 2026, TFF Pharmaceuticals, Inc. a une capitalisation boursière de $94.10K. Cela fait de TFF Pharmaceuticals, Inc. la 40710th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de TFF Pharmaceuticals, Inc. du 2019 au 2026
TFFP par rapport au top 5 des plus populaires stocks
Prix pour TFFP L’actif B La capitalisation boursière de B Résultats
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,775,383 $94.10K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.466T +5,808,281,050.57%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$3,077,935 $94.10K
Apple Inc. Apple Inc.
AAPL
$4.456T +4,735,284,137.96%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,883,583 $94.10K
Alphabet Inc. Alphabet Inc.
GOOG
$4.175T +4,436,281,069.66%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$2,547,265 $94.10K
Microsoft Corporation Microsoft Corporation
MSFT
$3.688T +3,918,868,801.49%
TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc.
$1,978,704 $94.10K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.865T +3,044,160,226.98%